コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 primary leucocytes following treatment with rhinovirus.
2 duced in epithelial cells by IL-13 and human rhinovirus.
3 tible to acute wheezing episodes provoked by rhinovirus.
4 ally prolonged, especially for bocavirus and rhinovirus.
5 in allergic asthmatic subjects infected with rhinovirus.
6 asynchronous circulation of influenza A and rhinovirus.
7 ild asthma were experimentally infected with rhinovirus.
8 up of 45- to 64-year-olds were attributed to rhinovirus.
9 tory syndrome (SARS), coxsackie viruses, and rhinoviruses.
10 ion of human respiratory syncytial virus and rhinoviruses.
11 ement among ICAM-1-binding enteroviruses and rhinoviruses.
12 eroviruses, it seems to occur more rarely in rhinoviruses.
13 enteroviruses but appears to be sporadic in rhinoviruses.
14 .7%) tested for other respiratory pathogens, rhinovirus (107 [12.8%]), adenovirus (64 [6.0%]), respir
19 response to an experimental inoculation with rhinovirus-16 among asthmatics with high levels of total
20 response to an experimental inoculation with rhinovirus-16 in allergic asthmatics with the response i
22 IFN beta (10(4) units) with fluticasone and rhinovirus 1B led to upregulation of interferon-inducibl
24 ytic degradation of eIF4G alone by the human rhinovirus 2A protease abrogated this translation strate
26 or adenovirus (100%), metapneumovirus (44%), rhinovirus (34%), and parainfluenza virus type 3 (28%);
27 ad life-threatening disease, 575 (24.8%) had rhinovirus, 347 (14.9%) had adenovirus (ADV), and 30 (1.
28 < .01), Coxsackieviruses (aOR 5.1, P = .09), rhinovirus A (aOR 3.5, P = .34), and rhinovirus C (aOR 2
29 on of rhinovirus C (OR, 2.85; P < 0.001) and rhinovirus A (OR, 2.92; P < 0.001), as well as, to a les
36 ma, early-life exposure to tobacco smoke and rhinovirus aetiology were early-life risk factors for la
37 ive samples; this risk was also present with rhinovirus alone (aHR for mortality, 2.6; 95% CI, 1.2-5.
38 th control mice treated with fluticasone and rhinovirus alone and improved viral clearance without ha
40 uch as respiratory syncytial virus (RSV) and rhinovirus, also seemed to have an impact on IPD: RSV co
41 ng immune mechanisms and interaction between rhinovirus and allergy remain enigmatic, and current par
42 e asthma AMs and was associated with reduced rhinovirus and imiquimod-induced IFN responses by these
43 zumab treatment were stimulated ex vivo with rhinovirus and influenza in the presence or absence of I
45 y chemokine responses of airway epithelia to rhinovirus and viral mimics and decreased nuclear transl
47 Interspecies recombination is even rarer for rhinoviruses and mostly is related to ancient events whi
48 infection by a broad panel of EVs, including rhinoviruses and non-polio EVs increasingly linked to se
50 ole of specific respiratory viruses, such as rhinoviruses and respiratory syncytial virus, in asthma
51 5 (1 of the 7 naturally pleconaril-resistant rhinoviruses) and OBR-5-340, a bioavailable pyrazolopyri
52 detections of parainfluenza, coronaviruses, rhinovirus, and adenovirus, especially in children, requ
54 l virus, parainfluenza viruses, coronavirus, rhinovirus, and human metapneumovirus, represent a consi
55 on with adenovirus, coronavirus, enterovirus/rhinovirus, and influenza virus (P = .062-.093), while m
56 for early inflammatory responses induced by rhinovirus, and TLR2(+) macrophages are sufficient to co
57 Omalizumab improved IFN-alpha responses to rhinovirus, and within the omalizumab group, greater IFN
60 on in respiratory viral infection.IMPORTANCE Rhinoviruses are one of the causes of the common cold.
62 ease, viral infections, including those with rhinovirus, are the commonest cause of exacerbations.
63 umans, including poliovirus, coxsackievirus, rhinovirus, as well as newly emerging global health thre
64 eas additional effort is needed in regard to rhinovirus, as well as other respiratory tract viruses.
70 za viruses, respiratory syncytial virus, and rhinoviruses being the most frequent and with the highes
72 ignaling drove the impaired IFN responses to rhinovirus by asthmatic alveolar macrophages (AMs); the
75 e significantly associated with detection of rhinovirus C (OR, 2.85; P < 0.001) and rhinovirus A (OR,
78 r which underlies variable susceptibility to rhinovirus-C infection and is associated with severe chi
79 ominant microbiota profile, while those with rhinovirus-C were more likely to have Moraxella-dominant
80 infection of the respiratory epithelium with rhinovirus can antagonize tolerance to inhaled antigen t
82 se, IL-33 levels were persistently high, and rhinovirus challenge exacerbated the type 2 inflammatory
83 ls were precisely monitored before and after rhinovirus challenge in allergic asthmatic subjects (tot
84 ere we devised a strategy based on the polio:rhinovirus chimera PVSRIPO, devoid of viral neuropathoge
85 raspecies recombination gives rise to viable rhinovirus chimeras in the polyprotein coding region and
90 Multiple infections with nearly identical rhinoviruses could be detected within each village, like
91 f infection by picornaviruses, such as human rhinovirus, coxsackievirus, poliovirus, foot-and-mouth d
96 cies rhinovirus/rhinovirus or rhinovirus/non-rhinovirus enterovirus recombinants are fully viable.
98 all detected respiratory viruses followed by rhinovirus/enterovirus (13%), influenza virus (12%), cor
99 he most common viruses detected by BFPP were rhinovirus/enterovirus (4.5%), influenza A virus (3%), a
100 ew York, from 2014 to 2018 were examined for rhinovirus/enterovirus (RhV/EV) by the FilmArray respira
101 re [ARF]), 21.3% had a virus detected (56.4% rhinovirus/enterovirus and 30.7% influenza/parainfluenza
103 ay (FA) respiratory panel was used to detect rhinovirus/enterovirus in respiratory specimens; suspect
104 arainfluenza virus 3, parainfluenza virus 4, rhinovirus/enterovirus, respiratory syncytial virus A an
106 ombination is described frequently among non-rhinovirus enteroviruses but appears to be sporadic in r
107 ombination is described frequently among non-rhinovirus enteroviruses, it seems to occur more rarely
112 Respiratory syncytial virus (RSV) and human rhinovirus (HRV) are the most common viruses associated
115 d whole blood samples during natural RSV and rhinovirus (hRV) infection (acute versus early recovery
121 aetiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectiou
122 nfections, caused by viruses including human rhinovirus (HRV), influenza virus, and respiratory syncy
127 ith acute respiratory infection due to human rhinovirus (HRV; n = 52) or respiratory syncytial virus
133 teristics and clinical significance of human rhinoviruses, human coronaviruses, human metapneumovirus
134 events with influenza virus, coronaviruses, rhinoviruses, human metapneumovirus, respiratory syncyti
135 at the 17q21 genetic locus who wheeze during rhinovirus illnesses have a greatly increased likelihood
136 tions, a mechanism through which IgE impairs rhinovirus immunity and underlies asthma exacerbations w
139 l human coronaviruses, influenza viruses and rhinoviruses in exhaled breath and coughs of children an
142 he magnitude of type 2 inflammation during a rhinovirus-induced acute exacerbation; however, only ant
143 ncreasing viral loads, fluticasone inhibited rhinovirus-induced airway inflammation as evidenced by s
145 wild-type, OVA-treated C57BL/6 mice blocked rhinovirus-induced airway responses, whereas transfer of
147 uggest that fluticasone treatment suppresses rhinovirus-induced airways inflammation in vivo but also
148 The role of type I interferon and PPRs in rhinovirus-induced asthma exacerbations in vivo are unce
151 ndings indicate that the regulation of human rhinovirus-induced B-cell responses could be a novel app
153 etermine the relationship between ORMDL3 and rhinovirus-induced ER stress and type I IFN in human leu
154 ociation between higher ORMDL3 and increased rhinovirus-induced HSPA5 and type I IFN gene expression.
155 es and transcription factors involved in the rhinovirus-induced interferon production and inflammator
156 rfactant protein C expression and suppressed rhinovirus-induced IP-10 secretion, which was associated
160 d rhinovirus- and influenza-induced PBMC and rhinovirus-induced pDC IFN-alpha responses in the presen
162 sufficient to recapitulate many features of rhinovirus-induced type-2 immune responses and asthma pa
163 ment of the first acute, moderate-to-severe, rhinovirus-induced wheezing episode in young children.
165 ecific monoclonal antibody is available; (b) rhinovirus-induced wheezing, associated with atopic pred
168 t-viral-challenge state resembled more other rhinovirus-infected asthmatics than their own pre-viral-
170 among asymptomatic controls with presence of rhinovirus infection (OR:4.23; 95%CI 1.16-14.22, p<0.05)
171 depletion after allergen challenge or during rhinovirus infection abrogated exacerbation of inflammat
172 , which was induced by allergen challenge or rhinovirus infection and conditioned pDCs for proinflamm
173 with exacerbation as the primary outcome and rhinovirus infection and respiratory illnesses as second
174 ent study collected individual data on human rhinovirus infection and sensitization to Alternaria and
175 f host double-stranded DNA (dsDNA) following rhinovirus infection and the exacerbation of type-2 alle
177 daptive capacity (AC) during an experimental rhinovirus infection in 24 healthy and asthmatic human v
179 ron and PRR expression at baseline and after rhinovirus infection in atopic asthmatic patients and co
183 nd polyinosinic-polycytidylic acid and human rhinovirus infection induced a potent antiviral protecti
187 tory T (Treg) cells, and we examined whether rhinovirus infection of the respiratory tract can block
189 lergic airway hypersensitivity, we show that rhinovirus infection triggers dsDNA release associated w
190 ma relate to the likelihood of exacerbation, rhinovirus infection, and respiratory illnesses during t
191 SV respiratory virus infection, asymptomatic rhinovirus infection, and virus-negative asymptomatic co
193 fficient for neutrophilic inflammation after rhinovirus infection, whereas macrophages treated with I
201 and non-respiratory syncytial virus (mostly rhinovirus) infection; profile B (49%), which has the la
203 ene-environment interactions (GEIs), such as rhinovirus infections, will improve detection of asthma
206 sociated with development of asthma, but how rhinovirus influences the immune response is not clear.
208 ted with inherent deficient IFN responses to rhinovirus, inhaled corticosteroids might interact syner
209 educed among allergic asthmatics early after rhinovirus inoculation but increased late in the infecti
215 anation for how different types (strains) of rhinoviruses may elicit different cell responses that di
216 43/NL63/HKU1/SARS/MERS), human enteroviruses/rhinoviruses, measles virus, mumps virus, Hepatitis A-E
217 espiratory syncytial virus (RSV), influenza, rhinovirus, metapneumovirus, and adenovirus was highly a
218 3.4%); picornavirus (enteroviruses [n = 14], rhinovirus [n = 5], and parechovirus [n = 2]), hepatitis
220 the first severe respiratory syncytial virus/rhinovirus-negative wheezing episode (adjusted OR, 8.0;
221 (UTR) interspecies rhinovirus/rhinovirus or rhinovirus/non-rhinovirus enterovirus recombinants are f
222 ected and examined for the presence of human rhinovirus or enterovirus using the FilmArray Respirator
223 ry virus types (respiratory syncytial virus, rhinoviruses, other picornaviruses, coronaviruses 229E a
225 its and hospitalizations were calculated and rhinovirus-positive and rhinovirus-negative patients wer
226 m severely ill patients nationwide, who were rhinovirus-positive or enterovirus-positive in hospital
227 ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor as a comparator) in sputum cells fro
231 ings demonstrate that in mouse airway cells, rhinovirus replicates preferentially at nasal cavity tem
234 ed 5' untranslated region (UTR) interspecies rhinovirus/rhinovirus or rhinovirus/non-rhinovirus enter
236 and III production associated with enhanced rhinovirus (RV) and respiratory syncytial virus (RSV) re
237 OXO3a and play an important role in clearing rhinovirus (RV) by mounting antiviral type I and type II
239 would shorten the frequency and duration of rhinovirus (RV) illnesses in children with allergic asth
241 ay epithelial cells are the major target for rhinovirus (RV) infection and express proinflammatory ch
250 ntiviral drugs to treat enterovirus (EV) and rhinovirus (RV) infections, which can be severe and occa
253 ng-associated respiratory tract infection by rhinovirus (RV) is a risk factor for asthma development.
254 -associated respiratory infection with human rhinovirus (RV) is associated with asthma development.
255 in causative agent of bronchiolitis, whereas rhinovirus (RV) is most commonly detected in wheezing ch
256 y-life respiratory syncytial virus (RSV) and rhinovirus (RV) lower respiratory tract infections (LRTI
259 an metapneumovirus (HMPV), adenovirus (AdV), rhinovirus (RV), bocavirus (BoV), and coronavirus (CoV).
260 ined as respiratory syncytial virus (RSV) or rhinovirus (RV), including coinfections with other virus
263 mucosal inflammation following experimental rhinovirus (RV)-16-induced COPD exacerbations and its re
264 TLR2 activation contributes to limitation of rhinovirus (RV)-induced IFN response in the airway epith
266 , target conserved regions in the capsids of rhinoviruses (RVs) and enteroviruses (EVs) by binding to
273 asthma have heightened antibody responses to rhinoviruses (RVs), although those specific for RV-C are
276 a preparation of a common cold virus (human rhinovirus serotype 2, HRV-A2) and (ii) the analysis of
277 may contribute to the very large numbers of rhinovirus serotypes that coexist while differing in vir
278 a subset known as the minor-group members of rhinovirus species A (RV-A) are correlated with the ince
281 Among 774 infants with severe bronchiolitis, rhinovirus species related to distinct nasopharyngeal mi
282 lyprotein region between members of the same rhinovirus species, but not between members of different
283 ay did not detect any other enteroviruses or rhinoviruses tested and did detect divergent strains of
285 arly and later life and then challenged with rhinovirus to model disease onset, progression, and chro
288 pes.IMPORTANCE Genetic variation among human rhinovirus types includes unexpected diversity in the ge
290 ature-dependent IFN induction in response to rhinovirus was dependent on the MAVS protein, a key sign
294 onal impact of other viruses such as RSV and rhinovirus was instead more important in the older popul
295 administering omalizumab on the response to rhinovirus was most pronounced during the early/innate p
300 ailable assays that detect enteroviruses and rhinoviruses without distinguishing between the two, inc